Vertex shares fall nearly 24% in six months on pipeline setbacks but strong CF sales and new launches may shape the future.

This biotech is a leader in the treatment of cystic fibrosis, and that’s helped earnings explode higher over the years. The ...

Their research led to the development of a drug that nearly doubles the life expectancy for adult cystic fibrosis patients.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Senior Vice President Paul Negulescu has been named as one of the winners of this year's Lasker~DeBakey Clinical Medical Researc ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Senior Vice President Paul Negulescu has been named ...

Vertex Pharmaceuticals Incorporated ( NASDAQ: VRTX) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 11:30 AM EDT Reshma Kewalramani - CEO, President & Director Duncan J.

A month has gone by since the last earnings report for Vertex Pharmaceuticals (VRTX). Shares have added about 6.9% in that time frame, outperforming the S&P 500. But investors have to be wondering, ...

TANZANIA’S first equity Exchange Traded Fund (ETF) merits a supportive “yes” at IPO. A measured subscription is both an investment and a vote for a deeper market in which households can own a ...

This project is a step-by-step learning journey where we implement various types of Triton kernels—from the simplest examples to more advanced applications—while exploring GPU programming with Triton.

H-1B visa changes 2025: United States Commerce Secretary Howard Lutnick called the popular H-1B visa program a “scam”, saying that American businesses should be focused on hiring American workers ...